News
The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
The researchers assessed prenatal exposures to smoking, alcohol, and stress (depression or anxiety) as well as maternal ...
The Washington State University Cowlitz County Extension SNAP-Ed program is putting on its third and final Farm to Family ...
3d
MedPage Today on MSNRFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor ProbeHHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
Several citations in the original report, which focuses on children’s health, referenced papers that did not exist. White ...
Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes (ECHO) Program ...
The White House released an expansive report that blames a crisis of chronic disease in children on ultraprocessed foods, chemical exposures, lack of physical activity, stress and excessive use of ...
As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...
Those aged 10-24 are confronting rising rates of chronic diseases, mental disorders and obesity, say experts calling for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results